Akinori Wada

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsSignal transductionMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 30, 2026
Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemia.

Yusuke Kamihara, Shohei Kikuchi, Nanako Ishikawa

|Feb 26, 2025
Identification of the Cellular Tipping Point in the Inflammation Model of LPS-Induced RAW264.7 Macrophages Through Raman Spectroscopy and the Dynamical Network Biomarker Theory.

Akinori Taketani, Shota Koshiyama, Takayuki Haruki

|Feb 10, 2024
Establishing Monoclonal Gammopathy of Undetermined Significance as an Independent Pre-Disease State of Multiple Myeloma Using Raman Spectroscopy, Dynamical Network Biomarker Theory, and Energy Landscape Analysis.

Shota Yonezawa, Takayuki Haruki, Keiichi Koizumi

|Aug 26, 2023
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

Eiji Kobayashi, Yusuke Kamihara, Miho Arai

|Aug 12, 2023
A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL.

Shohei Kikuchi, Akinori Wada, Yusuke Kamihara

|Apr 13, 2023
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.

Shohei Kikuchi, Akinori Wada, Yusuke Kamihara

Pageof 1

Frequent Collaborators

3 joint publications

Shohei Kikuchi

2 joint publications

Ryo Hatano

2 joint publications

Yoshihiro Hayakawa

2 joint publications

Yusuke Kamihara